| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin antagonizes G protein-coupled receptor (GPCR) signaling by blocking G protein interactions, thereby directly inhibiting downstream signaling of GPR113. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
YM-254890 is a selective Gq inhibitor; since GPR113 is coupled with Gq protein for its signaling, this chemical inhibits GPR113 function by blocking its primary signaling pathway. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go 6983 is a protein kinase C (PKC) inhibitor. PKC is downstream of Gq-coupled receptor activation; thus, Go 6983 inhibits GPR113 by hindering the activity of PKC that would be stimulated by GPR113 activation. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis Toxin inhibits Gi/o protein signaling. If GPR113 couples with Gi/o proteins, Pertussis Toxin would inhibit GPR113 functional responses mediated by such coupling. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
NF023 is a selective antagonist of P2X purinoceptor, which can inhibit GPR113 if GPR113's function is dependent on ATP release and subsequent P2X receptor activation, as it would impede the downstream signaling cascade. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
L-NAME inhibits nitric oxide synthase (NOS). If GPR113 functionally requires nitric oxide (NO) for its signaling process, inhibition of NOS by L-NAME would inhibit GPR113 signaling. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan is an angiotensin II receptor antagonist. It can inhibit GPR113 if the signaling of GPR113 is dependent on angiotensin II receptor activation as part of its signaling cascade. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK (Rho-associated kinase). If GPR113 signaling involves the Rho/ROCK pathway, inhibition of this kinase would impede downstream signaling of GPR113. | ||||||